Akebia Therapeutics Inc — 四半期財務統計 (NASDAQ:AKBA) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -4.47 M-13.59 M22.34 M28.11 M31.13 M-21.21 M 60.37 M 投資活動によるキャッシュフロー -2 000154 K-126 K-77 K-7.88 M-62 K -8.14 M 財務活動によるキャッシュフロー 22.32 M74.94 M1.72 M1.11 M-4.85 M-926 K -2.94 M フリーキャッシュフロー -4.47 M-13.59 M22.22 M28.03 M31.06 M-21.27 M 60.04 M

ニュース

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates

United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates

Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards?

Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

Are Options Traders Betting on a Big Move in Akebia Therapeutics Stock?

New Strong Sell Stocks for April 28th

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day - Slideshow (NASDAQ:AKBA) 2026-04-04

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day Transcript

Akebia Therapeutics, Inc. (AKBA) Presents at Leerink Global Healthcare Conference 2026 Transcript

Akebia、Leerinkカンファレンスで戦略的焦点をVafseoとパイプラインに

Akebia at Leerink Conference: Strategic Focus on Vafseo and Pipeline

3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts - TipRanks.com